Deals this week: Guiyang Xintian Pharmaceutical, TetraGenetics, Magenta Therapeutics

Chinese pharmaceutical company Guiyang Xintian Pharmaceutical has announced the pricing for its proposed initial public offering (IPO) of shares to raise ¥ 317.02m ($46m) in gross proceeds.

Source: Drug Development Technology - May 4, 2017 Category: Pharmaceuticals Source Type: news